Wednesday, Aug 10, 2022 | Last Update : 10:19 PM IST

drug manufacturers

COVID-19 vaccine boosters could mean billions for drugmakers

For Pfizer and Moderna, the boosters could be more profitable than the original doses because they won’t come with the R&D costs

26 Sep 2021 10:48 AM

Govt to procure 66 crore more doses of Covishield, Covaxin at revised rates

The price of each dose of Covishield amounts to Rs 215.25 and Covaxin Rs 225.75, including taxes

17 Jul 2021 12:53 PM

Samsung BioLogics loses USD 6 billion in stocks

Samsung BioLogics reported a 1.9 trillion won (USD 1.77 billion) net profit in 2015.

02 May 2018 12:23 PM

Humans may soon develop drugs from ants

Experiments with 20 ant species found antimicrobials on 12 of them, a team reported in the Royal Society Open Science journal.

07 Feb 2018 8:18 AM